DCVC is a venture capital firm based in Palo Alto, California, founded in 2010. The firm specializes in investing in seed and early-stage companies across various sectors, including artificial intelligence, exascale computing, climate technology, engineering, materials science, robotics, space, water, biology, defense, and security. With a team of experienced venture capitalists, technology entrepreneurs, and engineers, DCVC has a proven track record, having invested in over 150 companies and achieved 40 significant exits. In 2018, the firm expanded its focus with the launch of DCVC Bio, which invests in early-stage startups in computational biology. This branch targets innovations in synthetic biology, medicine, and agriculture, emphasizing teams that leverage advancements in genetic sequencing, artificial intelligence, and automation to drive transformative changes in the life sciences. Both divisions of DCVC are committed to supporting entrepreneurs who are advancing technology and creating impactful solutions in their respective fields.